Search All News
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
- June 6, 2018
Cachexia, the debilitating muscle wasting that occurs in late-stage cancer patients, may be due to an overload of zinc in muscles, finds a new study.
Source:Washington PostJune 4, 2018
- June 4, 2018
Joint pain relief from omega-3s may help more women adhere to hormonal breast cancer treatment, a study suggests.
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
- April 10, 2018
A new Science study from Columbia stem cell researchers has found that the liver is the surprising source of a growth factor that keeps bone marrow stem cells healthy.
- April 5, 2018
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
- February 28, 2018
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
- February 21, 2018
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
- February 12, 2018
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.